Apixaban/EdoxabanLack of efficacy : 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2048卷 / 1期

关键词：

D O I：

10.1007/s40278-025-78272-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：52 / 52

相关论文

共 50 条

[21] Apixaban/rivaroxabanIntracranial hemorrhage: 2 case reports
Reactions Weekly, 2022, 1905 (1) : 87 - 87
[22] Apixaban/rivaroxabanGastrointestinal bleeding: 2 case reports
Reactions Weekly, 2017, 1654 (1) : 54 - 54
[23] Apixaban/warfarin/rivaroxabanBleeding: 2 case reports
Reactions Weekly, 2017, 1657 (1) : 48 - 48
[24] Apixaban/rivaroxabanIntratumoral haemorrhage: 2 case reports
Reactions Weekly, 2023, 1967 (1) : 67 - 67
[25] Apixaban/rivaroxabanLack of efficacy and non major bleeding: 3 case reports
Reactions Weekly, 2022, 1889 (1) : 59 - 59
[26] Andexanet alfa/apixaban/rivaroxabanBleeding and lack of efficacy: 9 case reports
Reactions Weekly, 2019, 1767 (1) : 41 - 41
[27] Apixaban/rivaroxabanHeavy menstrual bleeding: 2 case reports
Reactions Weekly, 2021, 1841 (1) : 43 - 43
[28] Apixaban/thalidomideRash and major bleeding : 2 case reports
Reactions Weekly, 2019, 1750 (1) : 49 - 49
[29] Apixaban/edoxabanConvexity subarachnoid haemorrhage: 2 case reports
Reactions Weekly, 2020, 1827 (1) : 56 - 56
[30] Apixaban/enoxaparin-sodiumBleeding: 2 case reports
Reactions Weekly, 2024, 2031 (1) : 57 - 57

← 1 2 3 4 5 →